Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

17-beta-estradiol protects critical hippocampal synaptic circuits during asymptomatic disease in the novel TgF344-AD rat

Award Number: F31AG054087
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 03/01/2017
PERIOD OF PERFORMANCE END DATE: 02/28/2019

Group Awards By:

View Award Description

17-beta-estradiol protects critical hippocampal synaptic circuits during asymptomatic disease in the novel TgF344-AD rat - Project Summary This proposal aims to determine mechanisms by which the neuroprotective hormone 17¿-estradiol (E2) improves and maintains hippocampal synaptic signaling during presymtomatic Alzheimer’s disease (AD) pathology using the novel comprehensive TgF344-AD rat model. The earliest and most insidious stages of Alzheimer’s disease (AD) are characterized by altered brain function at the level of the synapse. Patholgoy begins in the entorhinal cortex (EC) and spreads via functionally connected synapse to the hippocampus. Both brain regions are critical to learning and memory. As soluble toxic species of amyloid beta oligomers and hyper-phosphorylated tau rise, EC-to- hippocampal synaptic weakening results and occurs decades prior to clinical presentation of cognitive symptoms. Ovarian hormones play a delicate role in modulating synaptic circuits and cognitive function. Rapid loss of ovarian hormones as a natural part aging in women is now recognized as a risk factor for the development of AD. 17¿-estradiol (E2) and its replacement post-menopause benefits neuron function, amyloid and tau pathology, and cognition, yet how E2 improves or maintains synaptic processes underlying cognitive function throughout early asymptomatic and symptomatic disease progression are unknown. Our lab has established that E2-enhanced hippocampal synaptic strength and cognitive performance, in non- diseased rodents, is due to its ability to increase synaptic current mediated by glutamate receptor subunit epsilon- 2 (GluN2B) –containing N-methyl D-aspartate receptors (NMDARs). Current evidence in presymptomatic transgenic rodent models show early hippocampal synaptic deficits result from loss of beneficial synaptic GluN2B-NMDARs transmission, while extrasynaptically located GluN2B-NMDARs are pathologically stimulated due to excessive extracellular glutamate. The current proposal will test the hypothesis that E2 is beneficial to synaptic function in early AD by enhancing synaptic GluN2B-NMDAR current and synaptic strength in the dentate gyrus, the primary target region of synaptic projections from EC. Data obtained in this proposal will bolster previous evidence of E2’s neuroprotective actions against Alzheimer’s disease pathology as well as establish novel therapeutic avenues.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2018 ( Subtotal = $35,096 )
2018	2018	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	001	2	5/17/2018	NON-COMPETING CONTINUATION	$480
2018	2018	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	002	2	6/20/2018	NON-COMPETING CONTINUATION	$0
2018	2018	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	2	12/15/2017	NON-COMPETING CONTINUATION	$34,616
														Subtotal = $35,096

Issue Date FY: 2017 ( Subtotal = $34,616 )
2017	2017	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	001	1	7/13/2017	NEW	$468
2017	2017	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	1	2/20/2017	NEW	$34,148
2017	2017	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	002	1	7/13/2017	NEW	$0
														Subtotal = $34,616

Grand Total All Awards = $69,712

Top

All Categories

About

Search

Reports

Data Submission

Award Information

17-beta-estradiol protects critical hippocampal synaptic circuits during asymptomatic disease in the novel TgF344-AD rat

Award Number: F31AG054087

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 03/01/2017

PERIOD OF PERFORMANCE END DATE: 02/28/2019

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer